Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes

被引:24
作者
Ghaderi, M
Wallin, KL
Wiklund, F
Zake, LN
Hallmans, G
Lenner, P
Dillner, J
Sanjeevi, CB
机构
[1] Karolinska Hosp, Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
[3] Umea Univ, Dept Oncol, Ctr Oncol, S-90187 Umea, Sweden
[4] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden
关键词
cervical cancer; CIN; HLA DR-DQ; HPV; MHC;
D O I
10.1002/ijc.10551
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The genes encoding human leukocyte antigens (HLA) have shown to be associated with cervical neoplasia. To obtain reliable data on HLA associations with cervical tumors, the study should be performed within a strictly defined cohort. To investigate the population attributable risk of cervical cancer associated with the HLA class 11 haplotypes DR15 and DQ6 (DQA1*0102 and DQB1*0602), we performed a nested case-control study of 85 women who developed invasive cervical cancer and 120 healthy women from a population-based cohort of Swedish women. The relative risks of cervical cancer among DR15 and DQ6-positive women were 3.73 [confidence interval (CI): 1.8-7.4] and 4.33 (CI: 2.1-8.5), corresponding to population attributable proportions of 27.9% and 30.8%, respectively. A susceptibility locus in the HLA class 11 region is involved in a substantial fraction of the etiology of cervical cancer. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:698 / 701
页数:4
相关论文
共 43 条
[1]   Cancer in twins: Genetic and nongenetic familial risk factors [J].
Ahlbom, A ;
Lichtenstein, P ;
Malmstrom, H ;
Feychting, M ;
Hemminki, K ;
Pedersen, NL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (04) :287-293
[2]   HLA AND HEPATITIS-B INFECTION [J].
ALMARRI, A ;
BATCHELOR, JR .
LANCET, 1994, 344 (8931) :1194-1195
[3]   COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN DR-DQ DISEASE ASSOCIATIONS FOUND WITH CERVICAL DYSPLASIA AND INVASIVE CERVICAL-CARCINOMA [J].
APPLE, RJ ;
BECKER, TM ;
WHEELER, CM ;
ERLICH, HA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06) :427-436
[4]  
Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO
[5]  
2-X
[6]   A PROTECTIVE ASSOCIATION BETWEEN THE HLA-A2 ANTIGEN AND NASOPHARYNGEAL CARCINOMA IN US CAUCASIANS [J].
BURT, RD ;
VAUGHAN, TL ;
NISPEROS, B ;
SWANSON, M ;
BERWICK, M .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (04) :465-467
[7]   MAP OF THE HUMAN MHC [J].
CAMPBELL, RD ;
TROWSDALE, J .
IMMUNOLOGY TODAY, 1993, 14 (07) :349-352
[8]  
Chua KL, 1996, CANCER, V77, P121, DOI 10.1002/(SICI)1097-0142(19960101)77:1<121::AID-CNCR20>3.0.CO
[9]  
2-6
[10]  
CHUA KL, 1995, ANAL QUANT CYTOL, V17, P221